Due to increasing evidence that PIM1 overexpression is linked with PCa progression, it will be valuable to investigate the AR T850 phosphorylation status in clinical samples of primary and advanced PCa using phosphospecific antibodies as was done for S94, S308, S650 and S791 [50]. Here, AR is linked to posterior cortical atrophy.